PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Art Pappas will sit on a panel titled "Getting the Funds You Need to Build and Grow Your Company" at the Specialty Pharmaceutical Conference sponsored by the Institute for International Research in Orlando.
News | 04. 11. 2007
